YESCARTA (Kite Pharma, Inc.)
Welcome to the PulseAid listing for the YESCARTA drug offered from Kite Pharma, Inc.. This pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.
| LABELER NAME / MANUFACTURER: | Kite Pharma, Inc. |
| NON-PROPRIETARY NAME: | axicabtagene ciloleucel |
| SUBSTANCE NAME: | AXICABTAGENE CILOLEUCEL |
| TYPE: | CELLULAR THERAPY |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-10-18 |
| END MARKETING DATE: | 0000-00-00 |
YESCARTA CELLULAR THERAPY Details:
| Item Description | YESCARTA from Kite Pharma, Inc. |
| LABELER NAME: | Kite Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2000000(1/68mL) |
| START MARKETING DATE: | 2017-10-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 71287-119_51bfd1c5-cbb2-48a1-a390-472955fefe1a |
| PRODUCT NDC: | 71287-119 |
| APPLICATION NUMBER: | BLA125643 |
Other AXICABTAGENE CILOLEUCEL Pharmaceutical Manufacturers / Labelers:
